Hims & Hers Health revenue and financials
$29.83Change from previous close: +1.22%Absolute change: +$0.36
In the fiscal year ended December 2025, Hims & Hers Health reported revenue of $2.35B (+59.00% year over year). Net income was $128.37M, a net margin of 5.5%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +59.00%
- 2025 vs 2024
- Net income growth
- +1.85%
- 2025 vs 2024
- Net margin
- 5.5%
- 2024: 8.5%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -35.9 | 89.4 | 61.3 | 149 | -19.1 | 109 | 86.4 | 85.3 | 53.6 | 25.8 | 22.0 | 25.2 |
| Depreciation and amortization | 29.5 | 22.0 | 18.1 | 17.7 | 10.5 | 8.3 | 6.1 | 4.4 | 3.6 | 3.0 | 2.7 | 2.4 |
| Capital expenditure | -25.9 | -29.8 | -59.4 | -65.3 | -46.1 | -55.3 | -24.5 | -3.3 | -3.2 | -10.6 | -8.6 | -3.3 |
| Investing cash flow | 84.5 | -15.4 | -83.7 | -887 | -21.1 | -32.8 | -17.2 | -10.4 | -4.5 | 13.0 | 20.7 | -31.1 |
| Financing cash flow | 342 | -77.9 | -97.5 | -39.0 | 889 | -23.0 | -13.7 | -38.8 | -25.1 | -30.3 | -4.0 | -1.6 |
| Share repurchases | -23.1 | -39.2 | -102 | -42.0 | -36.8 | -25.7 | -24.4 | -40.9 | -34.9 | -35.4 | -6.0 | -2.7 |
| Debt issued | 390 | — | 0.0 | 0.0 | 970 | — | — | — | — | — | — | — |
| Effect of exchange rates | -2.8 | -2.4 | 2.7 | -1.5 | 1.0 | 0.2 | -0.5 | 0.2 | -0.0 | 0.0 | -0.0 | 0.0 |
| Net change in cash | 388 | -6.4 | -117 | -779 | 850 | 53.5 | 55.1 | 36.2 | 24.1 | 8.6 | 38.7 | -7.4 |
| Free cash flow | -61.9 | 59.5 | 1.9 | 83.5 | -65.2 | 53.8 | 61.9 | 81.9 | 50.4 | 15.3 | 13.4 | 21.9 |
| Levered free cash flow | 588 | 102 | -22.4 | 170 | -81.2 | 38.7 | 62.1 | 72.5 | 38.4 | 4.8 | 11.1 | 28.1 |